ARL3 and neoplasm: Tumor cells rely on metabolic adaptability to sustain growth under stress, a process often linked to therapy resistance.[35, 42] Our discovery that ARL3 deficiency impairs oxidative phosphorylation (OXPHOS) and mitophagy through ERα‐dependent mechanisms reveals a novel axis connecting transcriptional and bioenergetic regulation.